A biopharmaceutical company AbbVie has donated one FibroScan to the Clinical Center in Montenegro. The cost of this device is around EUR90,000.

FibroScan is a device for non-invasive liver disease diagnosis. This means that most of the patients won’t have to go to biopsy anymore, nor go abroad for the non-invasive tests.

Thankful to the AbbVie for their donation, employees of the Clinical Center believe that the citizens of Montenegro will now get a better healthcare in their own country, but it will also lower Clinic’s expenses.

Top